Author:
Eustace Nicholas,Ladbury Colton,Liu Yufei,Amini Arya,Sampath Sagus,Watkins Tyler,Tsai Kevin,Maraghechi Borna,Han Chunhui,Shi Chengyu,Liu An,Williams Terence,Lee Percy
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Oligometastatic non-small cell lung cancer: current management;Román-Jobacho A;J Clin Transl Res,2021
2. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study;Gomez DR;Lancet Oncol,2016
3. Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer;Wang XS;J Natl Cancer Inst,2023
4. EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV non-small cell lung cancer (NSCLC): a prospective, multicenter, randomized, controlled phase II study;Peng P;Radiother Oncol,2023
5. Radiobiology for the radiologist;Hall EJ,2019